We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $172.86 · 7 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
[144] ICU MEDICAL INC/DE SEC Filing - Stock Titan
[144] ICU MEDICAL INC/DE SEC Filing Stock Titan
Icu Medical Inc/de Insider Sold Shares Worth $280,685, According to a Recent SEC Filing - marketscreener.com
Icu Medical Inc/de Insider Sold Shares Worth $280,685, According to a Recent SEC Filing marketscreener.com
[Form 4] ICU MEDICAL INC/DE Insider Trading Activity - Stock Titan
[Form 4] ICU MEDICAL INC/DE Insider Trading Activity Stock Titan
ICU Medical (ICUI) reshapes voting rules, rejects 10% special meeting bid - Stock Titan
ICU Medical (ICUI) reshapes voting rules, rejects 10% special meeting bid Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $1.91 | — | — | $534.23M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.63 | — | — | $604.7M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-3.85 | — | — | $1.75B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-2.51 | — | — | $1.16B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 27. | Needham | — | Upgrade | Hold → Buy | — | Needham: Hold → Buy |
| 2026. 04. 27. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2026. 04. 18. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 02. 20. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2026. 02. 20. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 11. 07. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.